World's Best Scientists 2026 revealed!
Kohei Miyazono

Kohei Miyazono

Award Badge
Molecular Biology
Japan
2026
Award Badge
Genetics and Molecular Biology
Japan
2024

D-Index & Metrics

Molecular Biology

D-Index
159
Citations
99869
World Ranking
67
National Ranking
4

Kohei Miyazono publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Kohei Miyazono sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 551 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Kohei Miyazono D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Kohei Miyazono sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 159 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Japan Leader Award
  • 2025 - Research.com Molecular Biology in Japan Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in Japan Leader Award
  • 2023 - Research.com Genetics and Molecular Biology in Japan Leader Award
  • 2023 - Research.com Molecular Biology in Japan Leader Award
  • 2022 - Research.com Genetics and Molecular Biology in Japan Leader Award
  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Kohei Miyazono is affiliated with the University of Tokyo in Japan and has contributed extensively to the fields of biochemistry, genetics, molecular biology, and medicine. Their research primarily focuses on molecular biology and oncology, with significant work in cancer research, pulmonary and respiratory medicine, and immunology.

The scientist's main research topics include:

  • TGF-β signaling in diseases
  • Cancer cells and metastasis
  • Epigenetics and DNA methylation
  • Renal and related cancers
  • Cell image analysis techniques
  • Cancer, hypoxia, and metabolism
  • Heterotopic ossification and related conditions

Notable recent papers authored or co-authored by Kohei Miyazono include:

  • TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation (2020), published in Cancer Science
  • Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series (2020), published in Critical Care
  • Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis (2020), published in Nature Cell Biology
  • TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness (2020), published in Oncogene
  • Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years (2022), published in Frontiers in Cell and Developmental Biology

Frequent publication venues where Kohei Miyazono's work has appeared include:

  • Cancer Science
  • Molecular Oncology
  • Journal of Biological Chemistry
  • Proceedings for Annual Meeting of The Japanese Pharmacological Society
  • STAR Protocols

The scientist collaborates regularly with a number of co-authors, including:

  • Daizo Koinuma
  • Shogo Ehata
  • Kei Takahashi
  • Jun Nishida
  • Masato Morikawa

Throughout their career, Kohei Miyazono has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS), an honor awarded in 2012.

Best Publications

  • TGF-beta signalling from cell membrane to nucleus through SMAD proteins

    Carl-Henrik Heldin;Kohei Miyazono;Peter ten Dijke

  • Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

    Masao Saitoh;Hideki Nishitoh;Makiko Fujii;Kohsuke Takeda

  • Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways

    Hidenori Ichijo;Eisuke Nishida;Kenji Irie;Peter ten Dijke

  • Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

    H. Cabral;Y. Matsumoto;K. Mizuno;Q. Chen

  • Modulation of microRNA processing by p53

    Hiroshi I. Suzuki;Kaoru Yamagata;Koichi Sugimoto;Takashi Iwamoto

  • TGFβ signalling: a complex web in cancer progression

    Hiroaki Ikushima;Kohei Miyazono

  • ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis

    Kei Tobiume;Atsushi Matsuzawa;Takumi Takahashi;Hideki Nishitoh

  • Smad6 inhibits signalling by the TGF-Beta superfamily

    Takeshi Imamura;Masao Takase;Ayako Nishihara;Eiichi Oeda

  • TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

    Atsuhito Nakao;Takeshi Imamura;Takeshi Imamura;Serhiy Souchelnytskyi;Masahiro Kawabata

  • Bone morphogenetic protein receptors and signal transduction

    Kohei Miyazono;Yuto Kamiya;Masato Morikawa

  • Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

    Toshio Kitamura;Tsuyoshi Tange;Takashi Terasawa;Shigeru Chiba

  • TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology

    Masato Morikawa;Rik Derynck;Kohei Miyazono

  • Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.

    Takanori Ebisawa;Minoru Fukuchi;Gyo Murakami;Tomoki Chiba

  • BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk

    Kohei Miyazono;Kohei Miyazono;Shingo Maeda;Takeshi Imamura

  • Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis

    S. Paul Oh;Tsugio Seki;Kendrick A. Goss;Takeshi Imamura

  • TGF-β signaling by Smad proteins

    Kohei Miyazono

  • Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.

    Kinichi Nakashima;Makoto Yanagisawa;Hirokazu Arakawa;Naoki Kimura

  • Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

    P Franzén;P ten Dijke;H Ichijo;H Yamashita

  • Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization.

    K Miyazono;U Hellman;C Wernstedt;C H Heldin

  • Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

    Fuyuki Ishikawa;Kohei Miyazono;Kohei Miyazono;Ulf Hellman;Hannes Drexler

Frequent Co-Authors

Takeshi Imamura
Takeshi Imamura Ehime University
Carl-Henrik Heldin
Carl-Henrik Heldin Uppsala University
Tetsuro Watabe
Tetsuro Watabe Tokyo Medical and Dental University
Keiji Miyazawa
Keiji Miyazawa University of Yamanashi
Hidenori Ichijo
Hidenori Ichijo University of Tokyo
Masahiro Kawabata
Masahiro Kawabata Japanese Foundation For Cancer Research
Fumimaro Takaku
Fumimaro Takaku University of Tokyo
Hiroyuki Aburatani
Hiroyuki Aburatani University of Tokyo
Ulf Hellman
Ulf Hellman Ludwig Cancer Research
Yasuyuki Morishita
Yasuyuki Morishita University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens doors to many interdisciplinary and specialized careers. As online education grows, students can now access a wide range of related degrees and certifications to expand their skill sets or pivot to new fields.

If you’re interested in a flexible, broad-based approach, consider the online interdisciplinary studies degree ranking affordable options. These programs often blend biology with other subjects, preparing graduates for diverse opportunities.

Those intrigued by life sciences in a historical or societal context might explore the best online master's in history programs. Such degrees can provide critical analytical skills useful in policy, research, or science communication.

Molecular biology also intersects with information management. Explore careers in medical or scientific information support by reviewing library science degree online programs, which can train you to organize and access critical research data.

For those drawn to biomedical sciences and healthcare, consider fast-tracking your qualifications with asha online slp programs to pursue careers in speech-language pathology.

Best Scientists Citing Kohei Miyazono

Trending Scientists

Recently Published Articles